Modulation of leukotriene signaling inhibiting cell growth in chronic myeloid leukemia

References

• Heisterkamp N, Stam K, Groffen J, et al. Structural organization of the bcr gene and its role in the Ph' translocation. Nature. 1985;315:758–761.
   PubMed Web of Science ®Google Scholar
• Höglund M, Sandin F, Hellström K, et al. Tyrosine kinase inhibitor usage, treatment outcome, and prognostic scores in CML: report from the population-based Swedish CML registry. Blood. 2013;122:1284–1292.
   PubMed Web of Science ®Google Scholar
• Gambacorti-Passerini C, Antolini L, Mahon FX, et al. Multicenter independent assessment of outcomes in chronic myeloid leukemia patients treated with imatinib. J Natl Cancer Inst. 2011;103:553–561.
   PubMed Web of Science ®Google Scholar
• Morotti A, Panuzzo C, Fava C, et al. Kinase-inhibitor-insensitive cancer stem cells in chronic myeloid leukemia. Expert Opin Biol Ther. 2014;14:287–299.
   PubMed Web of Science ®Google Scholar
• Haeggström JZ, Rinaldo-Matthis A, Wheelock CE, et al. Advances in eicosanoid research, novel therapeutic implications. Biochem Biophys Res Commun. 2010;396:135–139.
   PubMed Web of Science ®Google Scholar
• Basavarajappa D, Wan M, Lukic A, et al. Roles of coactosin-like protein (CLP) and 5-lipoxygenase-activating protein (FLAP) in cellular leukotriene biosynthesis. Proc Natl Acad Sci USA. 2014;111:11371–11376.
   PubMed Web of Science ®Google Scholar
• Shimizu T. Lipid mediators in health and disease: enzymes and receptors as therapeutic targets for the regulation of immunity and inflammation. Annu Rev Pharmacol Toxicol. 2009;49:123–150.
   PubMed Web of Science ®Google Scholar
• Funk CD. Lipoxygenase pathways as mediators of early inflammatory events in atherosclerosis. Arterioscler Thromb Vasc Biol. 2006;26:1204–1206.
   PubMed Web of Science ®Google Scholar
• Qiu H, Gabrielsen A, Agardh HE, et al. Expression of 5-lipoxygenase and leukotriene A4 hydrolase in human atherosclerotic lesions correlates with symptoms of plaque instability. Proc Natl Acad Sci USA.2006;103:8161–8166.
   PubMed Web of Science ®Google Scholar
• Savari S, Vinnakota K, Zhang Y, et al. Cysteinyl leukotrienes and their receptors: bridging inflammation and colorectal cancer. World J Gastroenterol. 2014;20:968–977.
   PubMed Web of Science ®Google Scholar
• Salim T, Sand-Dejmek J, Sjölander A. The inflammatory mediator leukotriene D4 induces subcellular β-catenin translocation and migration of colon cancer cells. Exp Cell Res. 2014;321:255–266.
   PubMed Web of Science ®Google Scholar
• Bäck M, Powell WS, Dahlén SE, et al. Update on leukotriene, lipoxin and oxoeicosanoid receptors: IUPHAR Review 7. Br J Pharmacol. 2014;171:3551–3574.
   PubMed Web of Science ®Google Scholar
• Theron AJ, Steel HC, Tintinger GR, et al. Cysteinyl leukotriene receptor-1 antagonists as modulators of innate immune cell function. J Immunol Res. 2014;2014:608930.
   PubMed Web of Science ®Google Scholar
• Stenke L, Samuelsson J, Palmblad J, et al. Elevated white blood cell synthesis of leukotriene C4 in chronic myelogenous leukaemia but not in polycythaemia vera. Br J Haematol. 1990;74:257–263.
   PubMed Web of Science ®Google Scholar
• Stenke L, Mansour M, Reizenstein P, et al. Stimulation of human myelopoiesis by leukotrienes B4 and C4: interactions with granulocyte-macrophage colony-stimulating factor. Blood. 1993;81:352–356.
   PubMed Web of Science ®Google Scholar
• Sjölinder M, Stenke L, Näsman-Glaser B, et al. Aberrant expression of active leukotriene C(4) synthase in CD16(+) neutrophils from patients with chronic myeloid leukemia. Blood. 2000;95:1456–1464.
   PubMed Web of Science ®Google Scholar
• Roos C, Stenke L, Ohm L, et al. Clinical imatinib mesylate treatment induces early normalisation of aberrant neutrophil leukotriene C4 synthase expression and activity in chronic myeloid leukaemia. Br J Haematol. 2008;142:992–995.
   PubMed Web of Science ®Google Scholar
• Chen Y, Hu Y, Zhang H, et al. Loss of the Alox5 gene impairs leukemia stem cells and prevents chronic myeloid leukemia. Nat Genet. 2009;41:783–792.
   PubMed Web of Science ®Google Scholar
• Chen Y, Li D, Li S. The Alox5 gene is a novel therapeutic target in cancer stem cells of chronic myeloid leukemia. Cell Cycle. 2009;8:3488–3492.
   PubMed Web of Science ®Google Scholar
• Matsuyama M, Hayama T, Funao K, et al. Overexpression of cysteinyl LT1 receptor in prostate cancer and CysLT1R antagonist inhibits prostate cancer cell growth through apoptosis. Oncol Rep. 2007;18:99–104.
   PubMed Web of Science ®Google Scholar
• Magnusson C, Ehrnström R, Olsen J, et al. An increased expression of cysteinyl leukotriene 2 receptor in colorectal adenocarcinomas correlates with high differentiation. Cancer Res. 2007;67:9190–9198.
   PubMed Web of Science ®Google Scholar
• Jabbour E, Kantarjian H. Chronic myeloid leukemia: 2016 update on diagnosis, therapy, and monitoring. Am J Hematol. 2016;91:252–265.
   PubMed Web of Science ®Google Scholar
• Sveinbjörnsson B, Rasmuson A, Baryawno N, et al. Expression of enzymes and receptors of the leukotriene pathway in human neuroblastoma promotes tumor survival and provides a target for therapy. Faseb J. 2008;22:3525–3536.
   PubMed Web of Science ®Google Scholar
• Savari S, Liu M, Zhang Y, et al. CysLT(1)R antagonists inhibit tumor growth in a xenograft model of colon cancer. PLoS One. 2013;8:e73466.
   PubMed Web of Science ®Google Scholar
• Paruchuri S, Sjölander A. Leukotriene D4 mediates survival and proliferation via separate but parallel pathways in the human intestinal epithelial cell line Int 407. J Biol Chem. 2003;278:45577–45585.
   PubMed Web of Science ®Google Scholar
• Magnusson C, Mezhybovska M, Lörinc E, et al. Low expression of CysLT1R and high expression of CysLT2R mediate good prognosis in colorectal cancer. Eur J Cancer. 2010;46:826–835.
   PubMed Web of Science ®Google Scholar
• Drost AC, Seitz G, Boehmler A, et al. The G protein-coupled receptor CysLT1 mediates chemokine-like effects and prolongs survival in chronic lymphocytic leukemia. Leuk Lymphoma. 2012;53:665–673.
   PubMed Web of Science ®Google Scholar
• Brechbiel J, Miller-Moslin K, Adjei AA. Crosstalk between hedgehog and other signaling pathways as a basis for combination therapies in cancer. Cancer Treat Rev. 2014;40:750–759.
   PubMed Web of Science ®Google Scholar
• Crews LA, Jamieson CH. Selective elimination of leukemia stem cells: hitting a moving target. Cancer Lett. 2013;338:15–22.
   PubMed Web of Science ®Google Scholar
• Tong WG, Ding XZ, Hennig R, et al. Leukotriene B4 receptor antagonist LY293111 inhibits proliferation and induces apoptosis in human pancreatic cancer cells. Clin Cancer Res. 2002;8:3232–323242.
   PubMed Web of Science ®Google Scholar
• Tong WG, Ding XZ, Talamonti MS, et al. Leukotriene B4 receptor antagonist LY293111 induces S-phase cell cycle arrest and apoptosis in human pancreatic cancer cells. Anticancer Drugs. 2007;18:535–541.
   PubMed Web of Science ®Google Scholar
• Lucas CM, Harris RJ, Giannoudis A, et al. Low leukotriene B4 receptor 1 leads to ALOX5 downregulation at diagnosis of chronic myeloid leukemia. Haematologica. 2014;99:1710–1715.
   PubMed Web of Science ®Google Scholar
• Fischer AS, Metzner J, Steinbrink SD, et al. 5-Lipoxygenase inhibitors induce potent anti-proliferative and cytotoxic effects in human tumour cells independently of suppression of 5-lipoxygenase activity. Br J Pharmacol. 2010;161:936–949.
   PubMed Web of Science ®Google Scholar
• Sud'ina GF, Pushkareva MA, Shephard P, et al. Cyclooxygenase (COX) and 5-lipoxygenase (5-LOX) selectivity of COX inhibitors. Prostaglandins Leukot Essent Fatty Acids. 2008;78:99–108.
   PubMed Web of Science ®Google Scholar
• Levy GN. Prostaglandin H synthases, nonsteroidal anti-inflammatory drugs, and colon cancer. Faseb J. 1997;11:234–247.
   PubMed Web of Science ®Google Scholar
• Edenius C, Stenke L, Tornhamre S, et al. Metabolism of granulocyte-derived leukotriene A4 in human platelets and respiratory tissue: transcellular formation of lipoxins and leukotrienes. Adv Exp Med Biol. 1991;314:281–288.
   PubMedGoogle Scholar
• Tornhamre S, Stenke L, Granzelius A, et al. Inverse relationship between myeloid maturation and leukotriene C4 synthase expression in normal and leukemic myelopoiesis-consistent overexpression of the enzyme in myeloid cells from patients with chronic myeloid leukemia. Exp Hematol. 2003;31:122–130.
   PubMed Web of Science ®Google Scholar